Welcome and introduction

ESCMID-appointed chair: Prof. Li Yang HSU

National University of Singapore, Public Health, Singapore, Singapore.

Chair: Prof. Jan Fehr

Department of Public & Global Health Travel Medicine and Infectious Diseases at the Epidemiology, Biostatistics and Prevention Institute (EBPI) at the University of Zurich, Zurich, Switzerland.

Cracking the code: correlates of protection for vaccinology

Dr Else Bijker

Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. NIHR Oxford Biomedical Research Centre, Oxford University Hospitals Trust, Oxford, UK.

Chikungunya vaccine development: utility of an immune surrogate

Prof. Lin Hwei Chen

Mount Auburn Travel Medicine Centre, Harvard Medical School, Division of Infectious Diseases and Travel Medicine, Mount Auburn Hospital, Cambridge, MA, USA.

Need for speed: generating mpox vaccine effectiveness data during a global outbreak

Dr Oriol Mitjà

Skin Neglected Tropical diseases and Sexually Transmitted Infections section, Fight Infectious Diseases Foundation, University Hospital Germans Trias i Pujol, Badalona, Spain.

From courage to confirmation: the impact of recent TBE vaccine effectiveness data

Prof. Robert Steffen

Epidemiology, Biostatistics and Prevention Institute WHO Collaborating Centre for Travelers’ Health University of Zurich, Zurich, Switzerland.

Division of Epidemiology, Human Genetics & Environmental Sciences, University of Texas School of Public Health, Houston, TX, USA.

Panel discussion and Q&A

All